With the availability of effective antiretroviral therapy (ART), many patients with HIV infection are now aging into older adulthood, while other older patients are receiving a diagnosis of HIV infection for the first time. The challenge: Not only managing the HIV infection, but also managing comorbidities, polypharmacy, drug-drug interactions, pharmacokinetic changes, frailty, and mental health. In this activity, three experts in the field provide practical advice to help older patients achieve optimal outcomes.
After completing this activity, participants should be better able to:
- Apply the most current Department of Health and Human Services recommendations for long-term management of aging patients with HIV and comorbidities
- Identify effective strategies for counseling patients with HIV and comorbidities to achieve optimal patient outcomes
- Select ART regimens that optimize long-term management of patients with HIV and consider individual patient factors and comorbidities
NPs and PAs
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until August 30, 2021. PAs should only claim credit commensurate with the extent of their participation.
PA planner: Jennifer Wohl, DHSc, PA-C, Eastern Virginia Medical School, Norfolk, Virginia
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an educational grant from Merck & Co., Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange are required to disclose to the audience any relevant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Eron: consultant: Merck; consultant/research investigator: Gilead, Janssen Pharmaceuticals, ViiV Healthcare.
Dr Kwong: speakers bureau: Gilead.
Dr Wohl: advisory board: Janssen Pharmaceuticals; advisory board/research grants: Gilead, Merck, ViiV Healthcare.
None of the members of the planning committee or PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: August 31, 2020
Expiration date: August 30, 2021
© 2021 Practicing Clinicians Exchange. All Rights Reserved. 98620MPCE